Skip to content
10-K

Annual Report

Histogen Inc.

0000950170-23-007056

← back to feed
Filed
Mar 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 8, 2023 4.27M sh
Shares Diluted FY 2022 · Dec 31, 2022 3.21M sh
Shares Diluted FY 2022 · Dec 31, 2021 1.92M sh
Capex FY 2022 · Dec 31, 2022 $216K
Capex FY 2022 · Dec 31, 2021 $241K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$9.68M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$14.53M
Cash And Equivalents FY 2022 · Dec 31, 2022 $12.11M
Cash And Equivalents FY 2022 · Dec 31, 2021 $18.69M
Stockholders Equity FY 2022 · Dec 31, 2022 $14.41M
Stockholders Equity FY 2022 · Dec 31, 2021 $21.19M
Current Liabilities FY 2022 · Dec 31, 2022 $1.23M
Current Liabilities FY 2022 · Dec 31, 2021 $2.33M
Total Liabilities FY 2022 · Dec 31, 2022 $5.7M
Total Liabilities FY 2022 · Dec 31, 2021 $7.06M
Current Assets FY 2022 · Dec 31, 2022 $13.46M
Current Assets FY 2022 · Dec 31, 2021 $21.61M
Total Assets FY 2022 · Dec 31, 2022 $19.07M
Total Assets FY 2022 · Dec 31, 2021 $27.25M
Eps Diluted FY 2022 · Dec 31, 2022 −$3.46
Eps Diluted FY 2022 · Dec 31, 2021 −$7.79
Eps Basic FY 2022 · Dec 31, 2022 −$3.46
Eps Basic FY 2022 · Dec 31, 2021 −$7.79
Sga Expense FY 2022 · Dec 31, 2022 $9.39M
Sga Expense FY 2022 · Dec 31, 2021 $7.8M
Rd Expense FY 2022 · Dec 31, 2022 $5.02M
Rd Expense FY 2022 · Dec 31, 2021 $8.47M
Operating Income FY 2022 · Dec 31, 2022 −$10.64M
Operating Income FY 2022 · Dec 31, 2021 −$15.46M
Revenue FY 2022 · Dec 31, 2022 $3.77M
Revenue FY 2022 · Dec 31, 2021 $1.03M